AR041690A1 - Derivados de piridoindolona substituidos en 3- por un grupo heterociclico su preparacion y su aplicacion en terapeutica - Google Patents
Derivados de piridoindolona substituidos en 3- por un grupo heterociclico su preparacion y su aplicacion en terapeuticaInfo
- Publication number
- AR041690A1 AR041690A1 ARP030103841A ARP030103841A AR041690A1 AR 041690 A1 AR041690 A1 AR 041690A1 AR P030103841 A ARP030103841 A AR P030103841A AR P030103841 A ARP030103841 A AR P030103841A AR 041690 A1 AR041690 A1 AR 041690A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- indolyl
- pyrazole
- application
- derivatives substituted
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- -1 N-oxidopyridyl Chemical group 0.000 abstract 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000001041 indolyl group Chemical group 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- WITMXBRCQWOZPX-UHFFFAOYSA-N 1-phenylpyrazole Chemical compound C1=CC=NN1C1=CC=CC=C1 WITMXBRCQWOZPX-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- YNHGMRWHXVMPEN-UHFFFAOYSA-N pyrrolo[2,3-f]quinolin-2-one Chemical group C1=CC=C2C3=NC(=O)C=C3C=CC2=N1 YNHGMRWHXVMPEN-UHFFFAOYSA-N 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0213270A FR2846330B1 (fr) | 2002-10-23 | 2002-10-23 | Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR041690A1 true AR041690A1 (es) | 2005-05-26 |
Family
ID=32088226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030103841A AR041690A1 (es) | 2002-10-23 | 2003-10-22 | Derivados de piridoindolona substituidos en 3- por un grupo heterociclico su preparacion y su aplicacion en terapeutica |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1556380B1 (enExample) |
| JP (1) | JP4599164B2 (enExample) |
| AR (1) | AR041690A1 (enExample) |
| AT (1) | ATE323091T1 (enExample) |
| AU (1) | AU2003292285A1 (enExample) |
| CY (1) | CY1105158T1 (enExample) |
| DE (1) | DE60304596T2 (enExample) |
| DK (1) | DK1556380T3 (enExample) |
| ES (1) | ES2263033T3 (enExample) |
| FR (1) | FR2846330B1 (enExample) |
| PT (1) | PT1556380E (enExample) |
| TW (1) | TW200418853A (enExample) |
| WO (1) | WO2004037821A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2823975B1 (fr) | 2001-04-27 | 2003-05-30 | Sanofi Synthelabo | Nouvelle utilisation de pyridoindolone |
| FR2846329B1 (fr) | 2002-10-23 | 2004-12-03 | Sanofi Synthelabo | Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique |
| FR2869316B1 (fr) | 2004-04-21 | 2006-06-02 | Sanofi Synthelabo | Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique. |
| FR2892416B1 (fr) * | 2005-10-20 | 2008-06-27 | Sanofi Aventis Sa | Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique |
| CN113365997B (zh) * | 2019-02-01 | 2022-06-07 | 南京明德新药研发有限公司 | 作为c-Met抑制剂的含嘧啶基团的三并环类化合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4263304A (en) * | 1978-06-05 | 1981-04-21 | Sumitomo Chemical Company, Limited | 7 H-indolo[2,3-c]isoquinolines |
| FR2765581B1 (fr) * | 1997-07-03 | 1999-08-06 | Synthelabo | Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique |
| FR2765582B1 (fr) * | 1997-07-03 | 1999-08-06 | Synthelabo | Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique |
-
2002
- 2002-10-23 FR FR0213270A patent/FR2846330B1/fr not_active Expired - Fee Related
-
2003
- 2003-10-21 DE DE60304596T patent/DE60304596T2/de not_active Expired - Lifetime
- 2003-10-21 WO PCT/FR2003/003111 patent/WO2004037821A1/fr not_active Ceased
- 2003-10-21 PT PT03767851T patent/PT1556380E/pt unknown
- 2003-10-21 ES ES03767851T patent/ES2263033T3/es not_active Expired - Lifetime
- 2003-10-21 AU AU2003292285A patent/AU2003292285A1/en not_active Abandoned
- 2003-10-21 DK DK03767851T patent/DK1556380T3/da active
- 2003-10-21 JP JP2004546105A patent/JP4599164B2/ja not_active Expired - Fee Related
- 2003-10-21 EP EP03767851A patent/EP1556380B1/fr not_active Expired - Lifetime
- 2003-10-21 AT AT03767851T patent/ATE323091T1/de active
- 2003-10-22 AR ARP030103841A patent/AR041690A1/es unknown
- 2003-10-22 TW TW092129284A patent/TW200418853A/zh unknown
-
2006
- 2006-07-12 CY CY20061100971T patent/CY1105158T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE323091T1 (de) | 2006-04-15 |
| DK1556380T3 (da) | 2006-08-14 |
| CY1105158T1 (el) | 2010-03-03 |
| JP4599164B2 (ja) | 2010-12-15 |
| AU2003292285A1 (en) | 2004-05-13 |
| DE60304596T2 (de) | 2007-05-10 |
| FR2846330A1 (fr) | 2004-04-30 |
| JP2006505577A (ja) | 2006-02-16 |
| FR2846330B1 (fr) | 2004-12-03 |
| ES2263033T3 (es) | 2006-12-01 |
| DE60304596D1 (de) | 2006-05-24 |
| TW200418853A (en) | 2004-10-01 |
| EP1556380B1 (fr) | 2006-04-12 |
| EP1556380A1 (fr) | 2005-07-27 |
| WO2004037821A1 (fr) | 2004-05-06 |
| PT1556380E (pt) | 2006-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200800555A1 (ru) | Производные ксантина в качестве селективных агонистов hm74a | |
| BRPI0408068A (pt) | derivados de 5-feniltiazol e seus usos como inibidores de pi3 cinase | |
| CY1114148T1 (el) | Γεφυρωμενες δικυκλικες αρυλο- και γεφυρωμενες δικυκλικες etepoapyλo-υποκατεστημενες τριαζολες χρησιμες ως αναστολεις toy axl | |
| WO2006078621A3 (en) | 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders | |
| ATE439837T1 (de) | 5-gliedrige heterocyclische p-38 inhibitoren | |
| NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
| BRPI0414136A (pt) | indóis substituìdos como inibidores de poli(adp-ribose) polimerase (parp) | |
| HRP20050710A2 (en) | Substituted n-arylheterocycles, method for production and use thereof as medicaments | |
| BR0309309A (pt) | Antagonistas de receptor de trombina tricìclicos | |
| NO20054082L (no) | Pyrazol`1,5-A! 1,3,5! triazinderivater som kannabinoidreseptorligander | |
| HUP0301431A2 (hu) | 3-Indolil-4-fenil-1H-pirrol-2,5-dion-származékok, mint glikogén szintáz kináz-3béta inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| JO2764B1 (en) | Indole derivatives or benzimidazole derivatives to modify the enzyme AKP kinase | |
| BRPI0515482A (pt) | derivados heterocìclicos e seus usos como agentes terapêuticos | |
| NZ533310A (en) | Benzimidazoles useful as protein kinase inhibitors | |
| BRPI0515477A (pt) | derivados heterocìclicos bicìclicos e o uso dos mesmos como inibidores de estaroil-coa-desaturase (scd) | |
| UA96565C2 (ru) | Пиридильные ингибиторы хеджхоговской передачи сигнала | |
| NO20075169L (no) | Nye imidazo (1,5-A)pyndindenvater, fremgangsmate for fremstilling og farmasoytiske sammensetninger som inneholder samme. | |
| BRPI0515478A (pt) | derivados heterocìclicos e seu uso como mediadores de estearoil-coa-desaturase | |
| DE502004006507D1 (de) | Imidazopyridazinon- und imidazopyridonderivate, deren herstellung und deren verwendung als arzneimittel | |
| BRPI0409367A (pt) | derivados de piperidina inibidores de renina | |
| DE60321808D1 (de) | Flavon derivate als inhibitoren von cyclin-abhängigen kinasen | |
| EA200701114A1 (ru) | Азоловые производные с антимускариновой активностью | |
| DE602005010970D1 (de) | Indol-derivate und ihre verwendung als kinase-hemmer, insbesondere ikk2-hemmer | |
| CY1109569T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
| UY29414A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |